SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the UZ Brussel Following COVID-19 Vaccination Using an Adenoviral Vector

NCT04939402 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

SARS-CoV-2
Covid19

Interventions

DIAGNOSTIC_TEST: Serological testing

Sponsor

Universitair Ziekenhuis Brussel